These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9254062)

  • 1. Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins.
    Ludwig EH; Hopkins PN; Allen A; Wu LL; Williams RR; Anderson JL; Ward RH; Lalouel JM; Innerarity TL
    J Lipid Res; 1997 Jul; 38(7):1361-73. PubMed ID: 9254062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity.
    Pullinger CR; Hennessy LK; Chatterton JE; Liu W; Love JA; Mendel CM; Frost PH; Malloy MJ; Schumaker VN; Kane JP
    J Clin Invest; 1995 Mar; 95(3):1225-34. PubMed ID: 7883971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel Arg-->Cys mutation in the LDL receptor that contributes to spontaneous hypercholesterolemia in pigs.
    Grunwald KA; Schueler K; Uelmen PJ; Lipton BA; Kaiser M; Buhman K; Attie AD
    J Lipid Res; 1999 Mar; 40(3):475-85. PubMed ID: 10064736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100.
    Soria LF; Ludwig EH; Clarke HR; Vega GL; Grundy SM; McCarthy BJ
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):587-91. PubMed ID: 2563166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia.
    Gaffney D; Reid JM; Cameron IM; Vass K; Caslake MJ; Shepherd J; Packard CJ
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1025-9. PubMed ID: 7627691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemia.
    Schmidt HH; Stuhrmann M; Shamburek R; Schewe CK; Ebhardt M; Zech LA; Büttner C; Wendt M; Beisiegel U; Brewer HB; Manns MP
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2167-74. PubMed ID: 9626156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.
    Myant NB; Gallagher JJ; Knight BL; McCarthy SN; Frostegård J; Nilsson J; Hamsten A; Talmud P; Humphries SE
    Arterioscler Thromb; 1991; 11(3):691-703. PubMed ID: 1674216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of apolipoprotein B gene variants with plasma apoB and low density lipoprotein (LDL) cholesterol levels.
    Deeb SS; Failor RA; Brown BG; Brunzell JD; Albers JJ; Motulsky AG; Wijsman E
    Hum Genet; 1992 Feb; 88(4):463-70. PubMed ID: 1346774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred.
    Haddad L; Day IN; Hunt S; Williams RR; Humphries SE; Hopkins PN
    J Lipid Res; 1999 Jun; 40(6):1113-22. PubMed ID: 10357843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric assessment of LDL ligand function for detection of heterozygous familial defective apolipoprotein B-100.
    Raungaard B; Heath F; Hansen PS; Brorholt-Petersen JU; Jensen HK; Faergeman O
    Clin Chem; 2000 Feb; 46(2):224-33. PubMed ID: 10657378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
    Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
    J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of allele-specific, receptor-binding-defective low density lipoproteins from familial defective apolipoprotein B-100 subjects.
    Arnold KS; Balestra ME; Krauss RM; Curtiss LK; Young SG; Innerarity TL
    J Lipid Res; 1994 Aug; 35(8):1469-76. PubMed ID: 7989871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R3531C mutation in the apolipoprotein B gene is not sufficient to cause hypercholesterolemia.
    Rabès JP; Varret M; Devillers M; Aegerter P; Villéger L; Krempf M; Junien C; Boileau C
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E76-82. PubMed ID: 11031227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
    Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U
    J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial moderate hypercholesterolemia caused by Asp235-->Glu mutation of the LDL receptor gene and co-occurrence of a de novo deletion of the LDL receptor gene in the same family.
    Koivisto UM; Gylling H; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1392-9. PubMed ID: 9261272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of apolipoprotein B to cholesterol in low density lipoproteins of patients with coronary heart disease.
    Vega GL; Grundy SM
    J Lipid Res; 1984 Jun; 25(6):580-92. PubMed ID: 6747462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
    Brugger D; Schuster H; Zöllner N
    Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation of apolipoprotein B-100 in circulating LDL is related to LDL residence time. In vivo insights from stable-isotope studies.
    Pietzsch J; Lattke P; Julius U
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E63-7. PubMed ID: 11031225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of apolipoprotein B100 polymorphisms that affect low-density lipoprotein metabolism: description of a new approach involving monoclonal antibodies and dynamic light scattering.
    Chatterton JE; Schlapfer P; Bütler E; Gutierrez MM; Puppione DL; Pullinger CR; Kane JP; Curtiss LK; Schumaker VN
    Biochemistry; 1995 Jul; 34(29):9571-80. PubMed ID: 7626627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.